Market Tracker

01/20 4:36am ET

Mylan NV (NASDAQ:MYL)

36.95
Delayed Data
As of Jan 19
 -0.24 / -0.65%
Today’s Change
33.60
Today|||52-Week Range
54.23
-3.15%
Year-to-Date

Today’s Trading

Previous close37.19
Today’s open37.11
Day’s range36.71 - 37.30
Volume4,062,738
Average volume (3 months)6,272,189
Market cap$19.9B
Dividend yield--
Data as of 01/19/2017

Growth & Valuation

Earnings growth (last year)-27.35%
Earnings growth (this year)+10.38%
Earnings growth (next 5 years)+7.03%
Revenue growth (last year)+21.91%
P/E ratio15.9
Price/Sales2.84
Price/Book1.87

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...-1.61-1.95%
INCYIncyte Corp+2.44+2.12%
BMRNBiomarin Pharmaceuti...-1.01-1.16%
BAXBaxter International...-0.20-0.43%
Data as of 01/19/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)$1.43
Annual revenue (last year)$9.5B
Annual profit (last year)$847.6M
Net profit margin8.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts